Mucosal model of immunization against human immunodeficiency virus type 1 with a chimeric influenza virus
about
Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodiesAlpha-C-galactosylceramide as an adjuvant for a live attenuated influenza virus vaccine.Identification and characterization of a peptide that specifically binds the human, broadly neutralizing anti-human immunodeficiency virus type 1 antibody b12Induction of Potent and Long-Lived Antibody and Cellular Immune Responses in the Genitorectal Mucosa Could be the Critical Determinant of HIV Vaccine Efficacy.A chimeric influenza virus expressing an epitope of outer membrane protein F of Pseudomonas aeruginosa affords protection against challenge with P. aeruginosa in a murine model of chronic pulmonary infection.Nasal immunization of mice with human papillomavirus type 16 (HPV-16) virus-like particles or with the HPV-16 L1 gene elicits specific cytotoxic T lymphocytes in vaginal draining lymph nodesGenetic subtypes, humoral immunity, and human immunodeficiency virus type 1 vaccine development.Hyperattenuated recombinant influenza A virus nonstructural-protein-encoding vectors induce human immunodeficiency virus type 1 Nef-specific systemic and mucosal immune responses in mice.Single HA2 mutation increases the infectivity and immunogenicity of a live attenuated H5N1 intranasal influenza vaccine candidate lacking NS1.Chimeric influenza virus hemagglutinin proteins containing large domains of the Bacillus anthracis protective antigen: protein characterization, incorporation into infectious influenza viruses, and antigenicity.Induction of HIV neutralizing antibodies against the MPER of the HIV envelope protein by HA/gp41 chimeric protein-based DNA and VLP vaccinesThe influence of delivery vectors on HIV vaccine efficacyInfluenza B virus requires BM2 protein for replicationGeneration of replication-competent recombinant influenza A viruses carrying a reporter gene harbored in the neuraminidase segmentA fusion intermediate gp41 immunogen elicits neutralizing antibodies to HIV-1Selective incorporation of influenza virus RNA segments into virions.Salivary binding antibodies induced by human immunodeficiency virus type 1 recombinant gp120 vaccine. The NIAID AIDS Vaccine Evaluation GroupHumoral, mucosal, and cellular immunity in response to a human immunodeficiency virus type 1 immunogen expressed by a Venezuelan equine encephalitis virus vaccine vector.Immunoglobulin G is the main protective antibody in mouse vaginal secretions after vaginal immunization with attenuated herpes simplex virus type 2Collectin-mediated antiviral host defense of the lung: evidence from influenza virus infection of miceRNA virus vectors: where are we and where do we need to go?Immunogenic properties of a trimeric gp41-based immunogen containing an exposed membrane-proximal external regionCharacterization of a neuraminidase-deficient influenza a virus as a potential gene delivery vector and a live vaccine.Engineering influenza viral vectorsTransfectant influenza A viruses are effective recombinant immunogens in the treatment of experimental cancerMucosal and systemic immune responses to a human immunodeficiency virus type 1 epitope induced upon vaginal infection with a recombinant influenza A virusEngineering Recombinant Reoviruses To Display gp41 Membrane-Proximal External-Region Epitopes from HIV-1Modulating immunogenic properties of HIV-1 gp41 membrane-proximal external region by destabilizing six-helix bundle structure.Induction of cellular immune responses to simian immunodeficiency virus gag by two recombinant negative-strand RNA virus vectors.Prediction and identification of a permissive epitope insertion site in the vesicular stomatitis virus glycoprotein.A neutralizing monoclonal antibody previously mapped exclusively on human immunodeficiency virus type 1 gp41 recognizes an epitope in p17 sharing the core sequence IEEE.
P2860
Q24561905-89788B8C-43B3-4A70-964E-294E93CAF318Q30377447-41C93215-3935-4050-A904-C56001446EC3Q30701127-611175C0-0AC3-46BF-AD39-5803F778BA7FQ33611645-91E651B5-DD59-41DF-8EBF-62B744FD92C9Q33760042-0B1ACF17-1826-4912-A3DA-A2DC91F76159Q33822614-F383AFE7-7691-48AC-A00F-6BB9F9EA6FFCQ33842152-BE8E27A3-9FF7-4980-9112-00B214F2FDE7Q33844931-4A26A825-E485-4C59-8B69-FFBFD93CCF7AQ33872175-889C60EE-ABDA-4C6B-B5FD-6B56EFF51717Q33908690-88A5AC10-20A9-45F6-A145-303F40871981Q33916676-2F7C0E3C-ABC6-4DC9-BFEA-4ACAB374CE7EQ34077543-81749DDF-E3ED-42D2-B690-F3303256BBCFQ34150785-CE00A7FF-21EE-4117-BD2A-15C479B16D04Q34296134-0152AC57-A39A-402A-9AFA-A4DAE4F07F8FQ34396912-10B549B7-EA40-4A82-A6F9-A159E0B35007Q34762920-307CCFFB-A858-4F84-8C43-02483B70DBD5Q35228349-12D35DDE-C980-40B2-A55D-18F61698DFB5Q35881081-33E9A592-CF83-4EE9-B48A-40660C590E2EQ35897726-AC33EBAD-8787-43AB-B4DC-C1E9BC284C77Q35897924-D2848317-82FD-4FC4-A698-41EC13D3F48AQ36080373-F72A10FE-37C2-456D-B97A-08D50ECCF7B2Q36372534-2ECBF122-9D43-4448-8B7F-EFB7581AF6FCQ36509477-4E9F7435-0BC3-4739-8D1F-EF717A586796Q36591871-A90ADA32-82AC-42BA-9F0A-AD74D4A7E534Q36916492-121AA1FE-9B9B-410A-B0C3-70CB41608C48Q36943971-9D8A081A-F11D-4372-90FD-60942FC7FE90Q36956100-B2A8D059-D74D-4E98-82A5-52C04A9E9DDDQ36978277-EE7F3C8C-1393-4958-BCCC-DC2497038E6FQ37348513-EB3CB107-56E3-46CF-B3C4-81D7310B11B4Q37730395-5981DD95-7B67-44E1-A92F-9CF17B25B517Q39878801-71454B65-48AB-4B7E-BD16-B55CC9A685FA
P2860
Mucosal model of immunization against human immunodeficiency virus type 1 with a chimeric influenza virus
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Mucosal model of immunization ...... ith a chimeric influenza virus
@ast
Mucosal model of immunization ...... ith a chimeric influenza virus
@en
type
label
Mucosal model of immunization ...... ith a chimeric influenza virus
@ast
Mucosal model of immunization ...... ith a chimeric influenza virus
@en
prefLabel
Mucosal model of immunization ...... ith a chimeric influenza virus
@ast
Mucosal model of immunization ...... ith a chimeric influenza virus
@en
P2093
P2860
P1433
P1476
Mucosal model of immunization ...... ith a chimeric influenza virus
@en
P2093
Engelhardt OG
García-Sástre A
Grassauer A
Purtscher M
P2860
P304
P407
P577
1995-11-01T00:00:00Z